sec filing
AB
NASDAQ · ABUS
Arbutus Biopharma Corporation
Healthcare · Biotechnology
$4.67
Down-$0.19 (-4.07%)
Updated Oct 7, 2026, 12:40 AM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 896.23M
- P/E ratio
- -21.14
- Dividend yield
- 0.00%
- 52-week range
- $4.01 – $5.45
- Volume
- 6.18M
- Avg. volume
- 1.58M
Price performance · ABUS
ABUS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
ABUS closed at $4.67 after 20 trading sessions, down 9.85% for the selected period.
- Last close
- $4.67
- Period change
- -9.85%
- Period low
- $4.45
- Period high
- $5.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $4.45 | $4.80 | $4.41 | $4.67 | 6.18M |
| Oct 2, 2026 | $4.55 | $4.68 | $4.375 | $4.45 | 8.99M |
| Oct 1, 2026 | $4.77 | $4.775 | $4.51 | $4.56 | 16.12M |
| Sep 30, 2026 | $4.675 | $4.95 | $4.675 | $4.78 | 16.88M |
| Sep 29, 2026 | $4.86 | $4.89 | $4.67 | $4.69 | 17.56M |
| Sep 28, 2026 | $4.84 | $4.88 | $4.80 | $4.86 | 11.67M |
| Sep 25, 2026 | $4.89 | $4.93 | $4.84 | $4.85 | 16.88M |
| Sep 24, 2026 | $4.85 | $4.885 | $4.8009 | $4.88 | 6.26M |
| Sep 23, 2026 | $5.01 | $5.02 | $4.84 | $4.85 | 10.84M |
| Sep 22, 2026 | $5.02 | $5.05 | $4.995 | $5.01 | 10.49M |
| Sep 21, 2026 | $5.03 | $5.07 | $4.99 | $5.00 | 4.56M |
| Sep 18, 2026 | $5.04 | $5.06 | $4.98 | $5.01 | 6.46M |
| Sep 17, 2026 | $5.10 | $5.10 | $5.04 | $5.07 | 2.72M |
| Sep 16, 2026 | $5.06 | $5.0891 | $5.02 | $5.05 | 4.01M |
| Sep 15, 2026 | $5.11 | $5.15 | $5.03 | $5.06 | 4.05M |
| Sep 14, 2026 | $5.12 | $5.16 | $5.095 | $5.13 | 3.8M |
| Sep 11, 2026 | $5.17 | $5.175 | $5.11 | $5.12 | 1.85M |
| Sep 10, 2026 | $5.11 | $5.165 | $5.10 | $5.12 | 2.45M |
| Sep 9, 2026 | $5.16 | $5.23 | $5.125 | $5.17 | 5.51M |
| Sep 8, 2026 | $5.10 | $5.20 | $5.08 | $5.18 | 5.29M |
Latest ABUS news
The latest Smart Investors Daily articles mentioning ABUS.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

